Close

Leerink Partners Cuts Price Target on Amgen (AMGN); Reiterates Market Perform

Go back to Leerink Partners Cuts Price Target on Amgen (AMGN); Reiterates Market Perform

Amgen (AMGN) Tops Q3 EPS by 23c

October 27, 2016 4:04 PM EDT

Amgen (NASDAQ: AMGN) reported Q3 EPS of $3.02, $0.23 better than the analyst estimate of $2.79. Revenue for the quarter came in at $5.8 billion versus the consensus estimate of $5.73 billion.

GUIDANCE:

Amgen sees FY2016 EPS of $11.40-$11.55, versus prior guidance of $11.10-$11.40 and... More

Trading Radar for 10/27: Alphabet (GOOG), Amazon (AMZN), Twitter (TWTR) Ford (F), Baidu.com (BIDU) Report

October 26, 2016 2:46 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 259kContinuing Claims - no Street consensusDurable Orders - Street sees 0.3%Durable Orders: ex. Transportation - Street sees 0.3%

Earnings:

Acorda Therapeutics (Nasdaq: ACOR) - no Street consensus
Aetna (NYSE: AET) - consensus EPS $2.03
Agenus (Nasdaq: AGEN) - consensus loss $0.29
Air Products (NYSE:... More